Pancreatic Cancer Research

ResearcherChinese University of Hong KongActive in the last 2 years

Junjie Hang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4750-9931; OpenAlex author ID A5084666528. Sources: OpenAlex.

Their work

Papers
15 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
34
Papers, trials and grants by year

2016: 3 papers · 2017: 2 papers · 2018: 1 paper · 2019: 2 papers · 2020: 1 paper · 2021: 4 papers · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 15

  1. PPP3CB inhibits pancreatic cancer progression by promoting ATOH8 translocation and transcriptionally regulating Sp1. Co-author DOI 10.1016/j.lfs.2025.123631↗
  2. A nomogram based on CT texture features to predict the response of patients with advanced pancreatic cancer treated with chemotherapy. Co-author DOI 10.1186/s12876-023-02902-4↗
  3. The role of phosphoprotein phosphatases catalytic subunit genes in pancreatic cancer. Co-author DOI 10.1042/bsr20203282↗
  4. Development and validation of a radiomics nomogram to discriminate advanced pancreatic cancer with liver metastases or other metastatic patterns. Co-author DOI 10.3233/cbm-210190↗
  5. Role of CT texture features for predicting outcome of pancreatic cancer patients with liver metastases. Co-author DOI 10.7150/jca.49569↗
  6. Clinical significance of site-specific metastases in pancreatic cancer: a study based on both clinical trial and real-world data. Co-author DOI 10.7150/jca.50317↗
  7. Lactate-Modulated Immunosuppression of Myeloid-Derived Suppressor Cells Contributes to the Radioresistance of Pancreatic Cancer. Co-author DOI 10.1158/2326-6066.cir-20-0111↗
  8. The clinical implication of CD45RA+ naïve T cells and CD45RO+ memory T cells in advanced pancreatic cancer: a proxy for tumor biology and outcome prediction. Co-author DOI 10.1002/cam4.1988↗
  9. A Systematic Inflammation-based Model in Advanced Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.7150/jca.30561↗
  10. Prediction of overall survival for metastatic pancreatic cancer: Development and validation of a prognostic nomogram with data from open clinical trial and rea… Co-author DOI 10.1002/cam4.1573↗
  11. Pretreatment C-reactive protein to albumin ratio for predicting overall survival in advanced pancreatic cancer patients. Co-author DOI 10.1038/s41598-017-03153-6↗
  12. Validation of Lymphocyte-to-Monocyte Ratio as a Prognostic Factor in Advanced Pancreatic Cancer: An East Asian Cohort Study of 2 Countries. First author DOI 10.1097/mpa.0000000000000891↗
  13. The M2 phenotype of tumor-associated macrophages in the stroma confers a poor prognosis in pancreatic cancer. First author DOI 10.1007/s13277-015-4741-z↗
  14. Simultaneous high expression of PLD1 and Sp1 predicts a poor prognosis for pancreatic ductal adenocarcinoma patients. Co-author DOI 10.18632/oncotarget.12447↗
  15. Sp1 and COX2 expression is positively correlated with a poor prognosis in pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/oncotarget.8593↗

Closest collaborators

The 25 strongest of 34 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lixia Wu · 8 shared papers, 2018–2025 · strength 1.08
  2. Kequn Xu · 5 shared papers, 2018–2021 · strength 0.54
  3. Siyuan Zhou · 3 shared papers, 2019–2021 · strength 0.38
  4. Xuguang Yang · 3 shared papers, 2019–2020 · strength 0.28
  5. Hua Jiang · 3 shared papers, 2018–2019 · strength 0.26
  6. Liwei Wang · 4 shared papers, 2016–2017 · strength 0.26
  7. Tiening Zhang · 2 shared papers, 2020–2021 · strength 0.24
  8. Xu Che · 1 shared paper, 2025 · strength 0.24
  9. Tao Liu · 1 shared paper, 2025 · strength 0.24
  10. Jingjing Li · 1 shared paper, 2023 · strength 0.22
  11. Haifeng Shi · 1 shared paper, 2023 · strength 0.22
  12. Yuli Lin · 2 shared papers, 2019–2020 · strength 0.19
  13. Hai Xia Hu · 3 shared papers, 2016 · strength 0.19
  14. Hanyu Zhou · 2 shared papers, 2019 · strength 0.18
  15. Tianliang Zhang · 1 shared paper, 2021 · strength 0.16
  16. Junjie Huang · 2 shared papers, 2016–2019 · strength 0.15
  17. Benny Chung-Ying Zee · 1 shared paper, 2021 · strength 0.14
  18. Weiyi Huang · 2 shared papers, 2017 · strength 0.13
  19. Peng Xue · 2 shared papers, 2017 · strength 0.13
  20. Haiyan Yang · 2 shared papers, 2016–2017 · strength 0.13
  21. Meng Zhuo · 2 shared papers, 2016 · strength 0.13
  22. Ting Han · 2 shared papers, 2016 · strength 0.13
  23. Feng Jiao · 2 shared papers, 2016 · strength 0.13
  24. Junfeng Zhang · 1 shared paper, 2020 · strength 0.10
  25. Liwei Wang · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.